ALRN
Aileron Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
James Brian Windsor
IPO Date
2017-06-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Aileron Therapeutics, Inc.
CEO
James Brian Windsor
IPO Date
2017-06-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 161 |
| $2.25 |
| 6 Dec 2024 | Aivado Manuel | director | A-Award | Acquired | 35,000 | $2.85 |
| 6 Dec 2024 | Ambros Reinhard J. | director | A-Award | Acquired | 35,000 | $2.85 |
| 6 Dec 2024 | Musso Alan A | director | A-Award | Acquired | 35,000 | $2.85 |
| 6 Dec 2024 | VON RICKENBACH JOSEF H | director | A-Award | Acquired | 35,000 | $2.85 |
| 6 Dec 2024 | Fairey William | director | A-Award | Acquired | 35,000 | $2.85 |
| 4 Dec 2024 | WINDSOR JAMES BRIAN | President and CEO | A-Award | Acquired | 517,500 | $2.85 |
| 22 Aug 2024 | Aivado Manuel | director | A-Award | Acquired | 2,725 | $2.40 |
| 22 Aug 2024 | Ambros Reinhard J. | director | A-Award | Acquired | 2,725 | $2.40 |